Susumu Ishiguro

554 total citations
44 papers, 405 citations indexed

About

Susumu Ishiguro is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Susumu Ishiguro has authored 44 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Susumu Ishiguro's work include Cancer Cells and Metastasis (6 papers), Algal biology and biofuel production (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Susumu Ishiguro is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Algal biology and biofuel production (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Susumu Ishiguro collaborates with scholars based in United States, Japan and Greece. Susumu Ishiguro's co-authors include Masaaki Tamura, Atsushi Kawabata, Setsuzo Tejima, Naomi Ohta, Jeffrey Comer, Kevin G. Becker, Deryl Troyer, Marla Pyle, Ravindra Thakkar and Cory Berkland and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Susumu Ishiguro

39 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susumu Ishiguro United States 13 163 64 39 35 35 44 405
Li Luo China 13 168 1.0× 41 0.6× 15 0.4× 22 0.6× 93 2.7× 75 628
Jung Eun Kim South Korea 11 156 1.0× 78 1.2× 48 1.2× 16 0.5× 48 1.4× 17 443
Tsvetelina Batsalova Bulgaria 14 152 0.9× 31 0.5× 26 0.7× 14 0.4× 30 0.9× 49 451
Jiajia Du China 15 166 1.0× 62 1.0× 19 0.5× 10 0.3× 26 0.7× 50 562
Yubo Sun China 11 200 1.2× 76 1.2× 50 1.3× 15 0.4× 15 0.4× 25 434
Yuanyuan Gao China 15 393 2.4× 48 0.8× 8 0.2× 58 1.7× 24 0.7× 41 772
Andrew M. Hau United States 14 296 1.8× 57 0.9× 40 1.0× 14 0.4× 89 2.5× 22 547
Sabine Middelhaufe Germany 6 512 3.1× 30 0.5× 34 0.9× 32 0.9× 109 3.1× 6 628
Chin‐Ju Park South Korea 16 462 2.8× 39 0.6× 13 0.3× 34 1.0× 34 1.0× 43 644

Countries citing papers authored by Susumu Ishiguro

Since Specialization
Citations

This map shows the geographic impact of Susumu Ishiguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Ishiguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Ishiguro more than expected).

Fields of papers citing papers by Susumu Ishiguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Ishiguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Ishiguro. The network helps show where Susumu Ishiguro may publish in the future.

Co-authorship network of co-authors of Susumu Ishiguro

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Ishiguro. A scholar is included among the top collaborators of Susumu Ishiguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Ishiguro. Susumu Ishiguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Thakkar, Ravindra, et al.. (2023). Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint. RSC Medicinal Chemistry. 14(4). 658–670. 16 indexed citations
4.
Thakkar, Ravindra, Susumu Ishiguro, Martin Conda‐Sheridan, et al.. (2023). De novodesign of a stapled peptide targeting SARS-CoV-2 spike protein receptor-binding domain. RSC Medicinal Chemistry. 14(9). 1722–1733. 6 indexed citations
5.
Ishiguro, Susumu, Ettayapuram Ramaprasad Azhagiya Singam, Ravindra Thakkar, et al.. (2022). Local immune checkpoint blockade therapy by an adenovirus encoding a novel PD-L1 inhibitory peptide inhibits the growth of colon carcinoma in immunocompetent mice. Translational Oncology. 16. 101337–101337. 3 indexed citations
6.
Tamura, Masaaki & Susumu Ishiguro. (2021). A Potential Application of Algae as a Complementary/Integrative Therapy in Veterinary Medicine. 5(2). 1–10. 1 indexed citations
7.
Ishiguro, Susumu, Ravindra Thakkar, Ayaka Nakashima, et al.. (2020). Water extract from Euglena gracilis prevents lung carcinoma growth in mice by attenuation of the myeloid-derived cell population. Biomedicine & Pharmacotherapy. 127. 110166–110166. 12 indexed citations
8.
Ishiguro, Susumu, Ravindra Thakkar, Ayaka Nakashima, et al.. (2020). Cell Wall Membrane Fraction of Chlorella sorokiniana Enhances Host Antitumor Immunity and Inhibits Colon Carcinoma Growth in Mice. Integrative Cancer Therapies. 19. 1871118987–1871118987. 17 indexed citations
9.
10.
Ishiguro, Susumu, et al.. (2016). Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice. Journal of Pharmaceutical Sciences. 106(1). 385–394. 16 indexed citations
11.
Ishiguro, Susumu, et al.. (2016). Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice. Pharmaceutical Research. 33(10). 2517–2529. 33 indexed citations
12.
Alhakamy, Nabil A., et al.. (2015). AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray. Molecular Cancer Therapeutics. 15(1). 209–218. 21 indexed citations
13.
Ohta, Naomi, Susumu Ishiguro, Atsushi Kawabata, et al.. (2015). Human Umbilical Cord Matrix Mesenchymal Stem Cells Suppress the Growth of Breast Cancer by Expression of Tumor Suppressor Genes. PLoS ONE. 10(5). e0123756–e0123756. 62 indexed citations
14.
Ishiguro, Susumu, Kiyoshi Yoshimura, Ryouichi Tsunedomi, et al.. (2015). Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Biology & Therapy. 16(2). 307–316. 20 indexed citations
15.
Kawabata, Atsushi, Naomi Ohta, Marla Pyle, et al.. (2013). Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses. Cytotherapy. 15(5). 586–597. 15 indexed citations
16.
Ishiguro, Susumu, Takeo Minematsu, Mitsuru Naito, Yukio KANAI, & Atsushi Tajima. (2009). Migratory Ability of Chick Primordial Germ Cells Transferred into Quail Embryos. Journal of Reproduction and Development. 55(2). 183–186. 12 indexed citations
17.
Ishiguro, Susumu, Shin‐ichi Ito, & Kimio Kunimori. (1998). Syngas conversion using RhVO4 and Rh2MnO4 catalysts: Regeneration and redispersion of Rh metal by calcination and reduction treatments. Catalysis Today. 45(1-4). 197–201. 19 indexed citations
18.
Ishiguro, Susumu, et al.. (1996). Improvement of Steel Quality by Advanced Tundish Technology in New Slab Caster at Kakogawa Works, Kobe Steel, Ltd.. ISIJ International. 36(Suppl). S81–S84. 2 indexed citations
19.
Ishiguro, Susumu, et al.. (1982). High-speed high-resolution gel permeation chromatography of small molecules and oligomers. Journal of Chromatography A. 239. 651–659. 6 indexed citations
20.
Ishiguro, Susumu & Setsuzo Tejima. (1968). Thiosugars. XIV. Studies on the Syntheses of 1, 2-Dideoxy-1, 2-dithioimidocarbonyl-β-D-mannopyranose and 1, 2-Dideoxy-1, 2-trithiocarbonyl-β-D-mannopyranose. Chemical and Pharmaceutical Bulletin. 16(10). 2040–2045. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Luo Breakdown of academic impact, for papers by Jung Eun Kim Breakdown of academic impact, for papers by Tsvetelina Batsalova Breakdown of academic impact, for papers by Jiajia Du Breakdown of academic impact, for papers by Yubo Sun Breakdown of academic impact, for papers by Yuanyuan Gao Breakdown of academic impact, for papers by Andrew M. Hau Breakdown of academic impact, for papers by Sabine Middelhaufe Breakdown of academic impact, for papers by Chin‐Ju Park
Rankless by CCL
2026